RA Capital Management - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.5%.

Quarter-by-quarter ownership
RA Capital Management ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$48,227,626
-31.4%
22,748,8800.0%0.95%
-28.5%
Q2 2023$70,294,039
-42.6%
22,748,8800.0%1.33%
-52.1%
Q1 2023$122,388,974
-19.1%
22,748,8800.0%2.77%
-9.7%
Q4 2022$151,280,052
+241.8%
22,748,880
+104.6%
3.07%
+225.0%
Q3 2022$44,261,000
-19.9%
11,120,9730.0%0.94%
-36.0%
Q2 2022$55,271,000
-17.7%
11,120,9730.0%1.47%
+0.5%
Q1 2022$67,171,000
-48.0%
11,120,9730.0%1.47%
-35.6%
Q4 2021$129,226,000
-25.9%
11,120,9730.0%2.28%
-5.7%
Q3 2021$174,377,000
-15.9%
11,120,9730.0%2.42%
-27.4%
Q2 2021$207,406,000
-56.7%
11,120,9730.0%3.33%
-53.9%
Q1 2021$479,314,00011,120,9737.23%
Other shareholders
VOR BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,692,429$124,814,00031.41%
Trustees of Columbia University in the City of New York 183,821$3,428,0005.06%
RA Capital Management 11,120,973$207,406,0003.33%
Johnson & Johnson Innovation - JJDC, Inc. 1,074,658$20,042,0002.05%
Sarissa Capital Management LP 707,010$13,186,0001.05%
SECTORAL ASSET MANAGEMENT INC 405,324$7,559,0000.61%
Woodline Partners LP 1,146,494$21,382,0000.40%
Artal Group S.A. 550,000$10,258,0000.21%
NEXPOINT ASSET MANAGEMENT, L.P. 50,000$933,0000.20%
Orbimed Advisors 833,333$15,542,0000.16%
View complete list of VOR BIOPHARMA INC shareholders